Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 4Lymphoma, Non-Hodgkin 3Triple Negative Breast Neoplasms 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Lymphoma 2Glioblastoma 2Burkitt Lymphoma 2Sarcoma, Synovial 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Liposarcoma, Myxoid 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1Ganglioneuroblastoma 1Fallopian Tube Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 16fludarabine 9Mycophenolic Acid 8Cytarabine 8venetoclax 7Busulfan 7fludarabine phosphate 6Whole-Body Irradiation 6Tacrolimus 5Cyclosporine 5ruxolitinib 4ponatinib 4Rituximab 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4Etoposide 4Daunorubicin 4blinatumomab 3asciminib 3Vincristine 3Prednisone 3Mercaptopurine 3Inotuzumab Ozogamicin 3Dexamethasone 3revumenib 2pegfilgrastim 2nilotinib 2ibrutinib 2Mesna 2Melphalan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Leukapheresis × 90 days × Clear all
NCT03226704 2026-05-20

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
120 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡